Cell signaling affects gene expression by regulating the activity of transcription factors. Here, we report that mitogen-activated protein kinase (MAPK) phosphorylation of Ets-1 and Ets-2, at a conserved site N terminal to their Pointed (PNT) domains, resulted in enhanced transactivation by preferential recruitment of the coactivators CREB binding protein (CBP) and p300. We discovered this phosphorylation-augmented interaction in an unbiased affinity chromatography screen of HeLa nuclear extracts by using either mock-treated or ERK2-phosphorylated ETS proteins as ligands. Binding between purified proteins demonstrated a direct interaction. Both the phosphoacceptor site, which lies in an unstructured region, and the PNT domain were required for the interaction. Minimal regions that were competent for induced CBP/p300 binding in vitro also supported MAPK-enhanced transcription in vivo. CBP coexpression potentiated MEK1-stimulated Ets-2 transactivation of promoters with Ras-responsive elements. Furthermore, CBP and Ets-2 interacted in a phosphorylation-enhanced manner in vivo. This study describes a distinctive interface for a transcription factor-coactivator complex and demonstrates a functional role for inducible CBP/p300 binding. In addition, our findings decipher the mechanistic link between Ras/MAPK signaling and two specific transcription factors that are relevant to both normal development and tumorigenesis.The connection of cell signaling to changes of gene expression represents a central step in many types of biological regulation. The Ras/mitogen-activated protein kinase (MAPK) pathway exemplifies the relevance of signaling to both normal development and disease. In this pathway, Ras, a GTPase, transmits extracellular signaling from receptor tyrosine kinases to two serine/threonine kinases (Raf and MEK) and, finally, to the activation of MAPKs. Upon nuclear import, MAPKs phosphorylate many different transcription factors, modulating DNA binding affinity, nuclear localization, stability, and interactions with coregulators (20, 58), thereby regulating gene expression. Genetic studies of Drosophila (54) and Caenorhabditis elegans (48) demonstrate that Ras/MAPK signaling plays a role in normal development. Furthermore, ϳ15 to 20% of all human tumors have an activating mutation in one of three ras genes (N-, K-, or H-ras), and oncogenic mutations in the B-raf gene have been identified for a wide variety of cancers, with 66% of all melanomas being affected (6,8). Although many of the components of Ras/MAPK signaling have been characterized, the full array of transcription factors affected is not known. Furthermore, the detailed mechanisms by which phosphorylation modulates transcription factors remain unclear in many cases.Multiple members of the ETS family of transcription factors are phosphorylated upon activation of the Ras/MAPK signaling pathway. For example, Elk-1 phosphorylation results in recruitment of the mediator complex via its Sur-2 (MED23) subunit (49), enhanced interaction with the coactivator p30...